Life sciences giant Bayer has announced a monumental $2.2bn capital investment dedicated to the construction of a cutting-edge pharmaceutical manufacturing…
Read More

Life sciences giant Bayer has announced a monumental $2.2bn capital investment dedicated to the construction of a cutting-edge pharmaceutical manufacturing…
Read More
Bayer has achieved a significant regulatory milestone with the US Food and Drug Administration (FDA) granting accelerated approval for its…
Read More
Bayer AG is set to significantly expand its presence in the ophthalmology market with the acquisition of Perfuse Therapeutics, a…
Read More